S. S. Jhee

479 total citations
13 papers, 329 citations indexed

About

S. S. Jhee is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, S. S. Jhee has authored 13 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Psychiatry and Mental health. Recurrent topics in S. S. Jhee's work include Cholinesterase and Neurodegenerative Diseases (5 papers), Epilepsy research and treatment (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). S. S. Jhee is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (5 papers), Epilepsy research and treatment (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). S. S. Jhee collaborates with scholars based in United States, Switzerland and Denmark. S. S. Jhee's co-authors include Mark Leibowitz, Larry Ereshefsky, Albert Enz, Gilbert Lefèvre, Neal R. Cutler, G Sędek, F. Pommier, Silke Appel‐Dingemanse, Heinz Schmidli and Victoria Zarotsky and has published in prestigious journals such as Biological Psychiatry, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

In The Last Decade

S. S. Jhee

13 papers receiving 318 citations

Peers

S. S. Jhee
Mark Leibowitz United States
Adel A. Gomaa Egypt
Serafina Chimirri Italy
Xuben Yu China
Michela Vitale Italy
Yoshikazu Yamamura Japan
Kara Lee Shirley United States
Kristine C. Willett United States
Satoru Kariya Japan
K.‐G. Jostell Sweden
Mark Leibowitz United States
S. S. Jhee
Citations per year, relative to S. S. Jhee S. S. Jhee (= 1×) peers Mark Leibowitz

Countries citing papers authored by S. S. Jhee

Since Specialization
Citations

This map shows the geographic impact of S. S. Jhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. S. Jhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. S. Jhee more than expected).

Fields of papers citing papers by S. S. Jhee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. S. Jhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. S. Jhee. The network helps show where S. S. Jhee may publish in the future.

Co-authorship network of co-authors of S. S. Jhee

This figure shows the co-authorship network connecting the top 25 collaborators of S. S. Jhee. A scholar is included among the top collaborators of S. S. Jhee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. S. Jhee. S. S. Jhee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bieck, P. R., Mark Leibowitz, D. Richard Lachno, et al.. (2016). Dihydroxyphenylglycol as a Biomarker of Norepinephrine Transporter Inhibition by Atomoxetine. Journal of Clinical Psychopharmacology. 36(6). 675–683. 6 indexed citations
2.
Ereshefsky, Larry, et al.. (2011). Strategies to accelerate drug development for CNS compounds. International Clinical Psychopharmacology. 26. e59–e59. 1 indexed citations
3.
Cutler, Neal R., et al.. (2009). Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease. Acta Neurologica Scandinavica. 97(4). 244–250. 44 indexed citations
4.
5.
Jhee, S. S., Mark Yen, Larry Ereshefsky, et al.. (2008). Low Penetration of Oseltamivir and Its Carboxylate into Cerebrospinal Fluid in Healthy Japanese and Caucasian Volunteers. Antimicrobial Agents and Chemotherapy. 52(10). 3687–3693. 47 indexed citations
6.
Lefèvre, Gilbert, G Sędek, S. S. Jhee, et al.. (2007). Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients. Clinical Pharmacology & Therapeutics. 83(1). 106–114. 106 indexed citations
7.
Jhee, S. S., Amy S. Chappell, Victoria Zarotsky, et al.. (2006). Multiple‐Dose Plasma Pharmacokinetic and Safety Study of LY450108 and LY451395 (AMPA Receptor Potentiators) and Their Concentration in Cerebrospinal Fluid in Healthy Human Subjects. The Journal of Clinical Pharmacology. 46(4). 424–432. 26 indexed citations
8.
Jhee, S. S., et al.. (2004). Similarity of Insulin Detemir Pharmacokinetics, Safety, and Tolerability Profiles in Healthy Caucasian and Japanese American Subjects. The Journal of Clinical Pharmacology. 44(3). 258–264. 18 indexed citations
9.
Jhee, S. S. & Victoria Zarotsky. (2003). Safety and Tolerability of Serial Cerebrospinal Fluid (CSF) Collections During Pharmacokinetic/Pharmacodynamic Studies: 5 Years Experience. Clinical Research and Regulatory Affairs. 20(3). 357–363. 7 indexed citations
10.
Gobburu, Jogarao, et al.. (2001). Pharmacokinetic‐Pharmacodynamic Modeling of Rivastigmine, a Cholinesterase Inhibitor, in Patients with Alzheimer's Disease. The Journal of Clinical Pharmacology. 41(10). 1082–1090. 33 indexed citations
11.
Cutler, N.R., et al.. (2000). 529. Pharmacokinetics of rivastigmine and its metabolite in patients with Alzheimer’s disease. Biological Psychiatry. 47(8). S161–S161. 3 indexed citations
12.
Cutler, N.R., Gary Friday, Lloyd Haskell, et al.. (1998). 157. NXX-066 in patients with Alzheimer's disease: A bridging study. Biological Psychiatry. 43(8). S47–S47. 1 indexed citations
13.
Cutler, N.R., et al.. (1997). Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin. Antimicrobial Agents and Chemotherapy. 41(6). 1298–1300. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Leibowitz Breakdown of academic impact, for papers by Adel A. Gomaa Breakdown of academic impact, for papers by Serafina Chimirri Breakdown of academic impact, for papers by Xuben Yu Breakdown of academic impact, for papers by Michela Vitale Breakdown of academic impact, for papers by Yoshikazu Yamamura Breakdown of academic impact, for papers by Kara Lee Shirley Breakdown of academic impact, for papers by Kristine C. Willett Breakdown of academic impact, for papers by Satoru Kariya Breakdown of academic impact, for papers by K.‐G. Jostell
Rankless by CCL
2026